Product Information
NICOTINE 2 MG LOZENGE is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3477 per EA under NDC 45802034405. Its NADAC has been published 629 times since Jun 11, 2014.
Strength
2 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802034405
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA077007On Market Since
3/31/2014
Pharmacological Classes
Price Statistics
The NADAC for NICOTINE 2 MG LOZENGE has been published 629 times since Jun 11, 2014, and over the history we have for it it has declined 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3477 per EA |
|---|---|
| All-time high | $0.3959 (Jun 10, 2020) |
| All-time low | $0.2537 (Apr 17, 2024) |
| 52-week high | $0.3504 |
| 52-week low | $0.3242 |
| Median price | $0.3535 |
| Average price | $0.3490 |
| Largest weekly change | +33.9% (Aug 21, 2024) |
| Weeks tracked | 629 |
| Tracking since | Jun 11, 2014 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NICOTINE 2 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for NICOTINE 2 MG LOZENGE, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3477 per EA (NDC 45802034405), effective Jun 24, 2026.
How has the price of NICOTINE 2 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for NICOTINE 2 MG LOZENGE has declined 7.0%. It has been tracked across 629 weekly CMS publications since Jun 11, 2014.
What are the highest and lowest recorded NADAC prices for NICOTINE 2 MG LOZENGE?
Since Jun 11, 2014, the NADAC for NICOTINE 2 MG LOZENGE has ranged from a low of $0.2537 (Apr 17, 2024) to a high of $0.3959 (Jun 10, 2020), with a median of $0.3535 per EA.
Are there cheaper alternatives to NICOTINE 2 MG LOZENGE?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, NICOTINE 2 MG CHEWING GUM, is $0.1967 per EA — about 43% below NICOTINE 2 MG LOZENGE.
Who manufactures NICOTINE 2 MG LOZENGE?
NICOTINE 2 MG LOZENGE (NDC 45802034405) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification